(Q36505493)

English

Macrolide immunomodulatory effects and symptom resolution in acute exacerbation of chronic bronchitis and acute maxillary sinusitis: a focus on clarithromycin

scientific article published on June 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

Macrolide immunomodulatory effects and symptom resolution in acute exacerbation of chronic bronchitis and acute maxillary sinusitis: a focus on clarithromycin (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

maxillary sinusitis

1 reference

based on heuristic

inferred from title

acute maxillary sinusitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

William R Bishai

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Expert Review of Anti-infective Therapy

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

405-416

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Trends in antimicrobial drug prescribing among office-based physicians in the United States.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Infectious exacerbations of chronic bronchitis: diagnosis and management

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance program

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Immunomodulatory activity and effectiveness of macrolides in chronic airway disease

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Macrolides and airway inflammation in children

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Macrolides for the treatment of chronic sinusitis, asthma, and COPD.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Improved lung function and body mass index associated with long-term use of Macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Anti-inflammatory effects of macrolides in lung disease

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

A measure of quality of life for clinical trials in chronic lung disease

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Diffuse panbronchiolitis in East Asia

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Immunomodulatory effects of quinolones

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Pharmacokinetics and tolerability of extended-release clarithromycin

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Pulmonary rehabilitation in patients with COPD

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Guidelines for the treatment of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Infectious etiology of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Antibiotic therapy of exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Diagnosis and treatment of upper respiratory tract infections in the primary care setting.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Canadian guidelines for the management of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Guidelines for the management of adult lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Acute community-acquired bacterial sinusitis: the value of antimicrobial treatment and the natural history

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Quality of life in treatment of acute rhinosinusitis with clarithromycin and amoxicillin/clavulanate

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Azithromycin inhibits the formation of flagellar filaments without suppressing flagellin synthesis in Salmonella enterica serovar typhimurium

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Role of neutrophil elastase in hypersecretion in asthma

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Treatment of Sinus Empyema in Adults: A Coordinated Nordic Multicenter Trial of Cefixime vs. Cefaclor

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.405

21 January 2018

Identifiers

10.1586/14787210.4.3.405

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36505493&oldid=1635729449"